Study description
A retrospective single‑institution study from Stanford University evaluated the clinical performance of Pintuition® in breast‑conserving surgery for non‑palpable lesions. Compared with the SCOUT® system, Pintuition® demonstrated equivalent oncologic outcomes while achieving a 21% shorter operative time, without compromise in margin status, specimen volume, or retrieval success. All Pintuition® markers were successfully detected and removed at the index procedure, supporting the role of surgical marker navigation in enabling efficient, predictable tumor excision.
Key messages
- Significantly shorter operative time observed with Pintuition®, with a median reduction of 13 minutes per case (21%) after adjustment for confounders
- Intuitive surgical marker navigation with TargetLOC™, combining visual and audible guidance to support precise alignment over the target
- Equivalent oncologic outcomes compared with SCOUT®, with identical positive margin and re‑excision rates (2.2%)
- 100% successful index‑operation retrieval of Pintuition® markers in the Stanford study
- Reliable marker detection throughout the procedure, including in the presence of blood, fluid, or hematoma
- No electrocautery interference, enabling uninterrupted navigation during surgery
- Potential operational benefits, as faster procedures may increase daily case throughput and reduce patient anesthesia time